Spain· ES:1201505001
BYFAVO 20 MG POLVO PARA SOLUCION INYECTABLE
A remimazolam product containing remimazolam, registered in Spain by Paion Pharma Gmbh. The same ATC class is registered in 14 of our 19 countries.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
Where it is registered
Remimazolam is registered in 14 of 19 countries.
Countries holding a registration under ATC N05CD14 (remimazolam), each read from that country’s own register.
- This record: Spain, from AEMPS CIMA (Spain)
- 9 of them publish a price we can compare per daily dose
Remimazolam · ATC N05CD14
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- remimazolam
- Manufacturer
- Paion Pharma Gmbh
- Country
- Spain (ES)
- ATC code
- N05CD14
- ATC class
- Remimazolam
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- June 3, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
71 interactions on record for remimazolam.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Remimazolam · interactions on record
71 records
- 4 severe
- 64 moderate
- 3 minor
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Remimazolam in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayByfavoPAION Pharma GmbH
- BelgiumByfavo 20 mgPaion Pharma
- CzechiaBYFAVOPAION Pharma GmbH, Aachen
- United KingdomByfavo 20mg powder for solution for injection vialsPAION Pharma GmbH
- PolandByfavoPAION Deutschland GmbH
- SwedenByfavo 20 mg Pulver till injektionsvätska, lösningPAION Pharma GmbH
- FinlandByfavoPAION Pharma GmbH
- IrelandByfavo 20 mg powder for solution for injectionPaion Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Byfavo
- Liechtenstein · Byfavo
- Norway · Byfavo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a2a3b0b7-95d2-49a7-b7f5-fca56ffebfb0 GET /v1/drugs/a2a3b0b7-95d2-49a7-b7f5-fca56ffebfb0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario. Psicótropos",
"estado": "{\"aut\":1690804365000}",
"nregistro": "1201505001",
"substance": "remimazolam"
}See everything about remimazolam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.